Comparison of Clinical Outcomes of Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.

被引：0
|
作者：
Wen, X. [1 ]
Casey, M. [1 ]
Santos, A. [1 ]
Hartzema, A. [2 ]
Womer, K. [1 ]
机构：
[1] Univ Florida, Dept Med, Gainesville, FL USA
[2] Univ Florida, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
289
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [1] Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients
    Wen, X.
    Casey, M. J.
    Santos, A. H.
    Hartzema, A.
    Womer, K. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3202 - 3211
  • [2] Utilization and clinical outcomes of belatacept- based immunosuppression in US renal transplant recipients
    Wen, Xuerong
    JinCasey, Michael
    Santos, Alfonso H.
    Hartzema, Abraham
    Womer, Karl
    TRANSPLANTATION, 2016, 100 (07) : S81 - S81
  • [3] Maintenance Belatacept- Based Immunosuppression in Lung Transplant Recipients
    Shoemaker, C.
    Floyd, S.
    Mannem, H.
    Sharma, B.
    Weder, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1030 - S1031
  • [4] Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression.
    Gattis, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 933 - 934
  • [5] Comparison of cardiovascular risk profiles and graft function between cyclosporine and tacrolimus-based immunosuppression in renal transplant recipients.
    Kim, Chan-Duck
    Bae, Ho-Sang
    Park, Sung-Won
    Park, Ja-Yong
    Shin, Yong-Bong
    Kang, Hyeock-Joo
    Park, Sun-Hee
    Kim, Yong-Lim
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 534 - 534
  • [6] Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression
    Mourad, G
    Garrigue, V
    Squifflet, JP
    Besse, T
    Berthoux, F
    Alamartine, E
    Durand, D
    Rostaing, L
    Lang, P
    Baron, C
    Glotz, D
    Antoine, C
    Vialtel, P
    Romanet, T
    Lebranchu, Y
    Al Najjar, A
    Hiesse, C
    Potaux, L
    Merville, P
    Touraine, JL
    Lefrancois, N
    Kessler, M
    Renoult, E
    Pouteil-Noble, C
    Cahen, R
    Legendre, C
    Bedrossian, J
    Le Pogamp, P
    Rivalan, J
    Olmer, M
    Purgus, R
    Mignon, F
    Viron, B
    Charpentier, B
    TRANSPLANTATION, 2001, 72 (06) : 1050 - 1055
  • [7] Clinical Safety of Belatacept Bridging Immunosuppression in Liver Transplant Recipients.
    Sparkes, T.
    Masters, B.
    Jason, M.
    Hanish, S.
    Ottmann, S.
    Klassen, D.
    Potosky, D.
    Hutson, W.
    Barth, R.
    LaMattina, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 711 - 711
  • [8] Clinical Safety of Belatacept Bridging Immunosuppression in Liver Transplant Recipients.
    Sparkes, T.
    Masters, B.
    Jason, M.
    Hanish, S.
    Ottmann, S.
    Klassen, D.
    Potosky, D.
    Hutson, W.
    Barth, R.
    LaMattina, J.
    TRANSPLANTATION, 2014, 98 : 711 - 711
  • [9] Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure
    Filler, G
    Womiloju, T
    Feber, J
    Lepage, N
    Christians, U
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (08) : 2005 - 2010
  • [10] Belatacept Vs. Tacrolimus: Clinical Outcomes in De Novo Kidney Transplant Recipients.
    Wongsaroj, P.
    Kahwaji, J.
    Vo, A.
    Choi, J.
    Villicana, R.
    Peng, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 457 - 457
12345